Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancerDan Yang, Anhui Shi, Rong Yu et al.|Thoracic Cancer|2020Cited by 16
Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma MarkersXin Sui, Weihu Wang, Leilei Jiang et al.|Frontiers in Oncology|2021Cited by 13